The American The World Health Organization estimates that multi- drug resistance accounts for more than 150,000 deaths each year from tuberculosis alone. ... The use of antibiotics as to promote growth in animals may also cause antibiotic resistance. The addition of ... and more »
Medical Xpress A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, ... and more »
Daily Mail She was treated with blood-thinning drugs but died on May 1, following a cardiac arrest. At an inquest into her death, pathologist Dr Richard Fitzmaurice said lying on her trolley could have contributed to her death. 'Immobility is a recognised factor ... and more »
OncLive Bevacizumab is monoclonal antibody that halts angiogenesis, or the formation of blood vessels, by blocking vascular endothelial growth factor -A (VEGF-A), which...
Science Daily (press release) ... for growth ," Mischel said. They discovered a complex but compelling series of consequential events: The EGFRvIII mutation controls expression of a splicing factor called HNRNPA1, which initiates an alternatively spliced form of a regulatory protein ...
pharmabiz.com Currently the most opted commonly used drug is the epidermal growth factor receptor (EGFR) which is known to provide a big relief in terms of symptoms control and also enable patients to lead a somewhat normal life, observed cancer specialists. While ...
MedPage Today CHICAGO -- Adding a growth factor to the immune-stimulating drug ipilimumab significantly improved overall survival in patients with metastatic melanom...
San Francisco Chronicle In 2012, the company hired 30 to 40 employees and will continue to hire to accommodate growth , including those with doctorate degrees, chemistry and biology degrees, financial backgrounds and other post-graduate degrees, Chien said. The CRO — contract ... and more »
